Aneurysm Research at University of Maryland Supported by OpenClinica EDC Platform
The University of Maryland School of Medicine uses OpenClinica's EDC platform to support their multi-center aneurysm trial.
OpenClinica, LLC announces that University of Maryland School of Medicine has selected the OpenClinica Enterprise Edition for the Ultra Registry, a multi-center aneurysm trial led by Dr. Gaurav Jindal, Professor of Diagnostic Radiology. The radiology department at the University of Maryland has state-of-the-art facilities and cutting-edge technologies, making it one of the most sophisticated in the world. The development and integration of nuclear medicine, ultrasonography, computed tomography and magnetic resonance imaging (MRI) has provided diagnostic imaging with an even more central role in diagnosis and selected (interventional) therapeutic procedures.
Gabrielle Messina, data manager and clinical research specialist for the Ultra Registry, chose OpenClinica based on the open architecture and the ability to receive professional training, not only on the OpenClinica system but on best practices in executing a clinical trial with an EDC system. “I took OpenClinica’s training in February of this year and the staff was committed to ensuring my success. I needed extra guidance, specific to my study, and the knowledgeable client services team took the time, outside of class, to make sure I understood how to build and validate my CRFs. The commitment and professionalism of the OpenClinica team was outstanding and confirmed not only the great value of this EDC system, but has given me peace of mind with my capacity to execute my trial,” said Gabrielle.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
